Rafferty Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.85M Buy
62,010
+7,399
+14% +$579K 0.02% 406
2025
Q1
$3.96M Sell
54,611
-12,276
-18% -$890K 0.02% 419
2024
Q4
$4.95M Buy
66,887
+5,788
+9% +$428K 0.02% 419
2024
Q3
$4.03M Sell
61,099
-4,434
-7% -$293K 0.01% 464
2024
Q2
$6.05M Buy
65,533
+2,940
+5% +$272K 0.02% 378
2024
Q1
$5.98M Buy
62,593
+849
+1% +$81.1K 0.02% 432
2023
Q4
$4.71M Sell
61,744
-1,685
-3% -$128K 0.02% 454
2023
Q3
$4.39M Buy
63,429
+4,785
+8% +$332K 0.03% 411
2023
Q2
$5.53M Buy
58,644
+3,330
+6% +$314K 0.03% 389
2023
Q1
$4.58M Buy
55,314
+2,131
+4% +$176K 0.03% 401
2022
Q4
$3.97M Buy
53,183
+20,054
+61% +$1.5M 0.03% 428
2022
Q3
$2.74M Buy
33,129
+18,044
+120% +$1.49M 0.03% 440
2022
Q2
$1.43M Sell
15,085
-3,998
-21% -$380K 0.01% 550
2022
Q1
$2.25M Sell
19,083
-1,901
-9% -$224K 0.01% 568
2021
Q4
$2.72M Buy
20,984
+1,110
+6% +$144K 0.01% 563
2021
Q3
$2.25M Buy
19,874
+6,076
+44% +$688K 0.02% 602
2021
Q2
$1.43M Buy
13,798
+908
+7% +$94K 0.01% 778
2021
Q1
$1.08M Buy
12,890
+962
+8% +$80.5K 0.01% 756
2020
Q4
$1.09M Sell
11,928
-30,655
-72% -$2.8M 0.01% 479
2020
Q3
$3.4M Sell
42,583
-10,281
-19% -$821K 0.04% 247
2020
Q2
$3.65M Sell
52,864
-5,201
-9% -$359K 0.05% 227
2020
Q1
$3.65M Buy
58,065
+41,172
+244% +$2.59M 0.15% 79
2019
Q4
$1.31M Buy
+16,893
New +$1.31M 0.02% 484
2017
Q4
Sell
-20,238
Closed -$737K 712
2017
Q3
$737K Buy
+20,238
New +$737K 0.02% 466
2017
Q2
Sell
-28,569
Closed -$896K 565
2017
Q1
$896K Buy
+28,569
New +$896K 0.02% 386
2016
Q4
Sell
-16,173
Closed -$650K 473
2016
Q3
$650K Sell
16,173
-1,395
-8% -$56.1K 0.02% 292
2016
Q2
$584K Sell
17,568
-35,634
-67% -$1.18M 0.04% 335
2016
Q1
$1.56M Buy
+53,202
New +$1.56M 0.09% 174
2014
Q3
Sell
-19,800
Closed -$283K 375
2014
Q2
$283K Buy
+19,800
New +$283K 0.05% 248